Sionna Therapeutics

IPO

Public · Waltham, United States · Founded 2019 · $293.0M raised

Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$293.0M
Last Round
$182.0M Series CMar 2024
Rounds
2
Type
Public

About

Sionna Therapeutics is a clinical-stage biopharmaceutical company founded in 2019 to develop novel treatments for cystic fibrosis by targeting NBD1, the site of the most common CF-causing mutation. The company is advancing a portfolio of NBD1 stabilizers and complementary CFTR modulators designed to work synergistically to normalize CFTR function beyond current approved therapies.

Summary

Sionna Therapeutics is a Biotech company based in Waltham, United States, founded in 2019. It has raised $293.0M in total across 2 rounds, most recently a $182.0M Series C round in Mar 2024. Investors include OrbiMed, T. Rowe Price and Atlas Venture.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

IPOFeb 2025
$219.2M

Sign up to see all 3 rounds

Series B through IPO — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Sionna Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/sionna-therapeutics"><img src="https://indexed.vc/api/badge/company/sionna-therapeutics" alt="Sionna Therapeutics on Indexed.vc" width="260" height="76" /></a>